Genetic Signature of Acute Lymphoblastic Leukemia and Netherton Syndrome Co-incidence-First Report in the Literature.
Netherton syndrome
children
leukemia
malignancy
mutation
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
10
2019
accepted:
09
12
2019
entrez:
4
2
2020
pubmed:
6
2
2020
medline:
6
2
2020
Statut:
epublish
Résumé
The aim of the following case report is to provide a description of acute lymphoblastic leukemia (ALL) in a patient with Netherton syndrome (NS). A 15-year-old male with NS was referred with suspicion of acute leukemia. Severe anemia, leukocytosis, thrombocytopenia, and elevated CRP level were demonstrated in pre-hospital laboratory tests. Physical examination revealed generalized ichthyosiform erythroderma. ALL was diagnosed on the basis of bone marrow biopsy. The patient was initially classified as CNS3 status. No signals indicating fusion of
Identifiants
pubmed: 32010610
doi: 10.3389/fonc.2019.01477
pmc: PMC6978700
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1477Informations de copyright
Copyright © 2020 Skoczen, Stepien, Mlynarski, Centkowski, Kwiecinska, Korostynski, Piechota, Wyrobek, Moryl-Bujakowska, Strojny, Rej, Kowalczyk and Balwierz.
Références
Blood. 2008 May 1;111(9):4477-89
pubmed: 18285545
J Clin Oncol. 2014 Sep 20;32(27):3012-20
pubmed: 25049327
Am J Hum Genet. 2000 Mar;66(3):914-21
pubmed: 10712206
Handb Exp Pharmacol. 2014;222:273-91
pubmed: 24756710
J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):116-23
pubmed: 7822652
Pediatr Dermatol. 2007 Jan-Feb;24(1):42-5
pubmed: 17300648
Pediatr Dermatol. 2017 Nov;34(6):e328-e330
pubmed: 29144034
Nat Genet. 2000 Jun;25(2):141-2
pubmed: 10835624
Oncotarget. 2017 Sep 16;8(52):89923-89938
pubmed: 29163799
J Allergy Clin Immunol. 2009 Sep;124(3):536-43
pubmed: 19683336
Arch Dermatol. 2001 Jun;137(6):747-50
pubmed: 11405764
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766
J Invest Dermatol. 2011 Sep;131(9):1947-50
pubmed: 21654837
Oncol Lett. 2016 Apr;11(4):2644-2650
pubmed: 27073532
Urology. 2015 Apr;85(4):e21-2
pubmed: 25817126
Exp Dermatol. 2013 Dec;22(12):820-4
pubmed: 24164484
Mol Diagn Ther. 2017 Apr;21(2):137-152
pubmed: 27905021
Acta Derm Venereol. 2013 Nov;93(6):727-8
pubmed: 23571873
Blood. 2014 Oct 9;124(15):2345-53
pubmed: 24829202
Blood. 2012 Apr 19;119(16):3815-9
pubmed: 22362038
J Clin Oncol. 2012 Jun 10;30(17):2094-101
pubmed: 22564992
Am J Hum Genet. 2008 Dec;83(6):769-80
pubmed: 19061985
Leuk Lymphoma. 2003 Jan;44(1):209-12
pubmed: 12691167
Br J Dermatol. 2011 Aug;165(2):263-8
pubmed: 21517795
Int J Mol Sci. 2017 Nov 15;18(11):null
pubmed: 29140280
Int J Biol Macromol. 2013 Sep;60:186-95
pubmed: 23748007
Clin Exp Immunol. 2017 Feb;187(2):251-258
pubmed: 27774581
J Clin Immunol. 2015 Nov;35(8):696-726
pubmed: 26482257
Ther Adv Hematol. 2013 Aug;4(4):270-90
pubmed: 23926459
J Am Acad Dermatol. 2010 Oct;63(4):607-41
pubmed: 20643494
Front Oncol. 2019 Apr 04;9:230
pubmed: 31019896
Br J Dermatol. 2001 May;144(5):1044-9
pubmed: 11359395
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):561-566
pubmed: 27913529
Cell Biol Toxicol. 2018 Oct;34(5):337-350
pubmed: 29623483
Cell Tissue Res. 2013 Feb;351(2):289-300
pubmed: 23344365
JAMA Dermatol. 2016 Apr;152(4):435-42
pubmed: 26865388
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9414-8
pubmed: 19470474
Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):464-470
pubmed: 28842136
Orphanet J Rare Dis. 2015 Mar 17;10:33
pubmed: 25886873
Oncol Lett. 2014 Sep;8(3):959-962
pubmed: 25120641
Int J Cancer. 2006 Nov 1;119(9):2001-6
pubmed: 16642469